The report analyzes and forecasts the Non-opioid pain patch market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of Non-opioid pain patch, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Non-opioid pain patch companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Non-opioid pain patch upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of Non-opioid pain patch and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Non-opioid pain patch market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Non-opioid pain patch market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Non-opioid pain patch market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Competitive Landscape
The report concludes with the profiles of major players in the global non-opioid pain patch market such as Acorda Therapeutics, Inc., ALLERGAN, Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co.,Inc., IBSA Institut Biochimque SA, Mylan N.V. , Pfizer, Inc., TEH SENG Pharmaceutical Mfg. Co., Ltd., and Teikoku Seiyaku Co., Ltd., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.
The global Non-opioid Pain Patch market has been segmented as follows:
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Non-opioid Pain Patch Market
4. Market Overview
4.1. Introduction
4.1.1. Non-opioid Pain Patch Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Non-opioid Pain Patch Market Analysis and Forecasts, 2017–2026
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Porter’s Five Force Analysis
4.7. Market Outlook
4.8. WHO Pain Ladder
4.9. Low Back Pain Prevalence (By Region & Countries
4.10. Patch Design Technologies: Snapshot
5. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Non-opioid Pain Patch Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Non-opioid Pain Patch Type, 2017–2026
5.4.1. Lidocaine Patches
5.4.2. Diclofenac Patches
5.4.3. Methyl Salicylate Patches
5.4.4. Capsaicin Patches
5.4.5. Ketoprofen Patches
5.4.6. Others
5.5. Market Attractiveness By Non-opioid Pain Patch Type
6. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Distribution Channels
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast By Distribution Channels, 2017–2026
6.4.1. Hospital Pharmacies
6.4.2. Online Pharmacies
6.4.3. Independent Pharmacies & Drug Stores
6.5. Market Attractiveness By Distribution Channels
7. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Policies and Regulations
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East and Africa
7.4. Market Attractiveness By Country/Region
8. North America Non-opioid Pain Patch Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.1.2. Policies and Regulations
8.1.3. Key Trends
8.2. Market Value Forecast By Non-opioid Pain Patch Type, 2017–2026
8.2.1. Lidocaine Patches
8.2.2. Diclofenac Patches
8.2.3. Methyl Salicylate Patches
8.2.4. Capsaicin Patches
8.2.5. Ketoprofen Patches
8.2.6. Others
8.3. Market Value Forecast By Distribution Channels, 2017–2026
8.3.1. Hospital Pharmacies
8.3.2. Online Pharmacies
8.3.3. Independent Pharmacies & Drug Stores
8.4. Market Value Forecast By Country, 2017–2026
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Non-opioid Pain Patch Type
8.5.2. By Distribution Channels
8.5.3. By Country
9. Europe Non-opioid Pain Patch Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast By Non-opioid Pain Patch Type, 2017–2026
9.2.1. Lidocaine Patches
9.2.2. Diclofenac Patches
9.2.3. Methyl Salicylate Patches
9.2.4. Capsaicin Patches
9.2.5. Ketoprofen Patches
9.2.6. Others
9.3. Market Value Forecast By Distribution Channels, 2017–2026
9.3.1. Hospital Pharmacies
9.3.2. Online Pharmacies
9.3.3. Independent Pharmacies & Drug Stores
9.4. Market Value Forecast By Country, 2017–2026
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Non-opioid Pain Patch Type
9.5.2. By Distribution Channels
9.5.3. By Country
10. Asia Pacific Non-opioid Pain Patch Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast By Non-opioid Pain Patch Type, 2017–2026
10.2.1. Lidocaine Patches
10.2.2. Diclofenac Patches
10.2.3. Methyl Salicylate Patches
10.2.4. Capsaicin Patches
10.2.5. Ketoprofen Patches
10.2.6. Others
10.3. Market Value Forecast By Distribution Channels, 2017–2026
10.3.1. Hospital Pharmacies
10.3.2. Online Pharmacies
10.3.3. Independent Pharmacies & Drug Stores
10.4. Market Value Forecast By Country, 2017–2026
10.4.1. India
10.4.2. China
10.4.3. Japan
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Non-opioid Pain Patch Type
10.5.2. By Distribution Channels
10.5.3. By Country
11. Latin America Non-opioid Pain Patch Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3.. Key Trends
11.2. Market Value Forecast By Non-opioid Pain Patch Type, 2017–2026
11.2.1. Lidocaine Patches
11.2.2. Diclofenac Patches
11.2.3. Methyl Salicylate Patches
11.2.4. Capsaicin Patches
11.2.5. Ketoprofen Patches
11.2.6. Others
11.3. Market Value Forecast By Distribution Channels, 2017–2026
11.3.1. Hospital Pharmacies
11.3.2. Online Pharmacies
11.3.3. Independent Pharmacies & Drug Stores
11.4. Market Value Forecast By Country, 2017–2026
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Non-opioid Pain Patch Type
11.5.2. By Distribution Channels
11.5.3. By Country
12. Middle East and Africa Non-opioid Pain Patch Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast By Non-opioid Pain Patch Type, 2017–2026
12.2.1. Lidocaine Patches
12.2.2. Diclofenac Patches
12.2.3. Methyl Salicylate Patches
12.2.4. Capsaicin Patches
12.2.5. Ketoprofen Patches
12.2.6. Others
12.3. Market Value Forecast By Distribution Channels, 2017–2026
12.3.1. Hospital Pharmacies
12.3.2. Online Pharmacies
12.3.3. Independent Pharmacies & Drug Stores
12.4. Market Value Forecast By Country, 2017–2026
12.4.1. South Africa
12.4.2. GCC Countries
12.4.3. Rest of Middle East and Africa
12.5. Market Attractiveness Analysis
12.5.1. By Non-opioid Pain Patch Type
12.5.2. By Distribution Channels
12.5.3. By Country
13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Market Share Analysis By Company - 2016 (Expected)
13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.3.1. Acorda Therapeutics, Inc.
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.2. ALLERGAN
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.3. Endo International plc
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.4. GlaxoSmithKline plc
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.5. Hisamitsu Pharmaceutical Co.,Inc.
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.6. IBSA Institut Biochimque SA
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.7. Mylan N.V.
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.8. Pfizer, Inc.
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.9. TEH SENG Pharmaceutical Mfg. Co., Ltd.
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.10. Teikoku Seiyaku Co., Ltd.
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.11. Others
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers